Healthcare There's more to dopamine than we thought New research reveals dopamine’s precision in the brain, offering deeper insights into conditions like ADHD and reminding us why policy must evolve alongside science.
Healthcare Vyvanse Supply and Quality Issues ADHD Australia is aware of growing concerns about the availability and quality of Vyvanse
Individuals What's behind the rise in ADHD cases? To many parents of affected children, it is a condition that is going under-recognised and needs better resourcing. But to sceptics, like Lincoln psychiatrist Dr Sami Timimi, ADHD is a prime example of “overmedicalisation“.
Healthcare NSW GPs To Diagnose, Treat & Manage ADHD Game changing reforms allow GPs to treat ADHD to reduce wait times and costs.
Healthcare Major Parties Commit To Cut The Cost Of Your Medication ADHD Australia welcomes bipartisan support to cut medication costs under the PBS, a crucial step toward affordability, equity and better support for Australians living with ADHD.
Healthcare WA Parties promise to make access to treatment easier WA takes a step forward on ADHD care with election promises to cut wait times and allow GPs to diagnose. ADHD Australia urges other states to follow suit.
Healthcare Tasmania Announces Inquiry Into ADHD Services ADHD Australia welcomes the Tasmanian Government’s newly announced inquiry into ADHD services a vital step toward better support, assessment and treatment access. With personal advocacy from MP Simon Behrakis, this inquiry opens the door for Tasmanians with lived experience to be heard.
Healthcare Senate Makes 15 Key Recommendations, Now What? The Senate Inquiry into ADHD revealed major barriers in diagnosis, support and access to services. With over 700 submissions and 15 key recommendations, the final report is now out.
Healthcare Vyvanse to cost less in big win for Adult ADHDers Over the past few months, we have asked the ADHD community to support us in changing the way ADHD medications are made availability under the Pharmaceutical Benefits Scheme (PBS).